ŌURA Snags $200M, Hits $5.2B Valuation
Fidelity Management & Research Company and Dexcom participated in ŌURA’s $200 million Series D round. The post ŌURA Snags $200M, Hits $5.2B Valuation appeared first on MedCity News.
Read More
A Biotech Startup’s Quest to Relieve Pulmonary Mucus Obstruction for Respiratory Care
In response to emailed questions, the founders of MucoLife Therapeutics shared their company’s approach, which is designed to help people with COPD, cystic fibrosis, asthma, and pulmonary fibrosis. The post A Biotech Startup’s Quest to Relieve Pulmonary Mucus Obstruction for Respiratory Care appeared first on MedCity News.
Positive Development Rakes In $51.5M To Grow Developmental Therapy Model for Autism
Positive Development’s Series C round was co-led by aMoon, B Capital and Flare Capital Partners, and included participation from Digitalis Ventures and Healthworx. The post Positive Development Rakes In $51.5M To Grow Developmental Therapy Model for Autism appeared first on MedCity News.
Ex-Eye Bank Workers Say Pressure, Lax Oversight Led to Errors
William Lopez remembers clearly the day in June 2017 when he says he was asked to call the spouse of a college friend who had just died and ask for her eyes. The spouse hadn’t responded to calls from other employees at the Rocky Mountain Lions Eye Bank, he said. As Lopez recalled, his supervisor…
Do We Need Humans in the Loop? A Novo Nordisk Exec Weighs In (Video)
Thomas Senderovitz, senior vice president of data science at Novo Nordisk, challenges conventional notions about AI and the need for humans in the loop. The post Do We Need Humans in the Loop? A Novo Nordisk Exec Weighs In (Video) appeared first on MedCity News.
Breast Cancer Rises Among Asian American and Pacific Islander Women
Christina Kashiwada was traveling for work during the summer of 2018 when she noticed a small, itchy lump in her left breast. She thought little of it at first. She did routine self-checks and kept up with medical appointments. But a relative urged her to get a mammogram. She took the advice and learned she…
3 Things to Know About Medtech Investment, From a VC
At a recent conference, Maria Berkman — who serves as head of medtech at Broadview Ventures and managing director at Longview Ventures — shared insights into the somewhat niche ecosystem of medtech investment. The post 3 Things to Know About Medtech Investment, From a VC appeared first on MedCity News.
States Target Ultraprocessed Foods in Bipartisan Push
California Republican James Gallagher, the GOP’s former Assembly leader, has often accused the state’s progressive lawmakers of heavy-handed government intrusion, but this year he added his name to a legislative push for healthier school meals. His party followed suit, with all but one Republican voting to send a bill to Democratic Gov. Gavin Newsom that…
Neurocrine Lands FDA Nod for First New Treatment in Decades for Rare Endocrine Disorder
Neurocrine Biosciences’ Crenessity is now FDA approved for treating classic congenital adrenal hyperplasia (CAH), a rare and potentially fatal endocrine disorder. The approval comes with a priority review voucher, which Neurocrine could sell for around $150 million. The post Neurocrine Lands FDA Nod for First New Treatment in Decades for Rare Endocrine Disorder appeared first…
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
September has seen a wide range of executive hires, exits, promotions and layoffs across the healthcare industry. For example, Medtronic, Amgen and Kaiser Permanente welcomed new executives. There were also layoffs at organizations including Novo Nordisk and Seattle Children’s. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity…